Related Experiment Video
Updated: Jun 16, 2026
09:24
In Vitro Scratch Assay to Demonstrate Effects of Arsenic on Skin Cell Migration
Published on: February 23, 2019
[Correlation between mTOR signaling transduction pathway and arsenic trioxide response]
1Department of Hematology, Shengjing Hospital, China Medical Univercity, Shenyang 110004, Liaoning Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|February 9, 2010
Summary
Arsenic trioxide (ATO) activates the mTOR signaling pathway in K562/DNR cells. Inhibiting this pathway with LY294002 or rapamycin enhances ATO-induced apoptosis, offering potential therapeutic strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- The mTOR signaling pathway regulates cell growth and survival.
- Arsenic trioxide (ATO) is used in cancer treatment, but its precise mechanisms are still being explored.
- Understanding ATO's interaction with key cellular pathways is crucial for optimizing its efficacy.
Purpose of the Study:
- To investigate the correlation between the mTOR signaling pathway and the effects of arsenic trioxide (ATO).
- To determine how ATO influences the expression of key proteins in the mTOR pathway.
- To evaluate the combined effect of ATO and mTOR inhibitors on cancer cell apoptosis.
Main Methods:
- Western blot analysis to detect protein expressions of pmTOR, pAKT, and pP70S6K.
- Flow cytometry to assess apoptosis rates in K562/DNR cells.
- Treatment of K562/DNR cells with ATO, LY294002, and rapamycin.
Main Results:
- ATO treatment increased the expression of pmTOR, pAKT, and pP70S6K in K562/DNR cells.
- Combined treatment with ATO and mTOR inhibitors (LY294002 or rapamycin) significantly increased apoptosis rates.
- ATO was found to activate the mTOR signaling pathway in a dose- and time-dependent manner.
Conclusions:
- The mTOR signaling pathway is activated by arsenic trioxide in K562/DNR cells.
- Inhibitors of the mTOR pathway potentiate the apoptotic effects of ATO.
- Targeting the mTOR pathway could enhance ATO-based cancer therapies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:22Diversity in Cell Signaling Responses
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity.
Graded and Abrupt Responses
Some signaling systems generate...
Graded and Abrupt Responses
Some signaling systems generate...